Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUTORPHANOL vs CABAZITAXEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUTORPHANOL vs CABAZITAXEL: Safety Overview

Metric BUTORPHANOL CABAZITAXEL
Total FAERS Reports 462 2,553
Deaths Reported 10 467
Death Rate 2.2% 18.3%
Hospitalizations 24 950
Average Patient Age 53.9 yrs 68.7 yrs
% Female Patients 79.2% 2.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Dec 29, 2021
Manufacturer Hikma Pharmaceuticals USA Inc. Sanofi-Aventis U.S. LLC
Route NASAL N/A
Marketing Status Discontinued Prescription